Physician

Shemin Gupta, MD

According to 2025 Medicare claims, Shemin Gupta, MD (NPI: 1609015528) practices medical oncology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32763-8399. Gupta is affiliated with the Complete Health Accountable Care LLC (ACO ID: D0036), participating under the REACH model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 963 traditional Medicare patients, billed 281,184 HCPCS/CPT codes, and received $3,160,694 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,031 prescription claims across 407 beneficiaries totaling $2,990,837 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 117 records totaling $2,396. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,144,768 to $3,160,694. Similarly, Part D prescription costs have moved sharply higher in recent years, from $574,161 to $2,990,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	594	88,692	$1,144,768
2016	675	204,127	$1,697,091
2017	733	212,105	$2,004,598
2018	779	265,139	$2,485,288
2019	753	281,894	$2,421,187
2020	764	349,600	$2,502,066
2021	747	358,826	$3,378,259
2022	771	354,829	$3,652,870
2023	971	342,957	$3,553,591
2024	963	281,184	$3,160,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	710	$574,161
2016	172	858	$831,386
2017	202	912	$862,111
2018	231	1,126	$1,170,452
2019	232	1,118	$1,420,527
2020	282	1,195	$1,304,081
2021	254	1,078	$1,238,133
2022	240	1,150	$1,747,268
2023	379	1,707	$2,145,842
2024	407	2,031	$2,990,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$516
2016	N/R	N/R	N/R
2017	N/R	16	$7,802
2018	N/R	43	$4,610
2019	N/R	168	$91,725
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$1,334

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	553	1,353	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	435	746	$13
96372	Injection of drug or substance under skin or into muscle	299	1,576	$10
36415	Insertion of needle into vein for collection of blood sample	771	2,421	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	755	2,673	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	45	1,183	$757,948
Pomalyst	Pomalidomide	24	672	$518,946
Jakafi	Ruxolitinib Phosphate	23	690	$409,073
Eliquis	Apixaban	177	6,975	$133,069
Abiraterone Acetate	Abiraterone Acetate	33	973	$48,751

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	11	$1,334

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$2,396	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shemin Gupta, MD?

Tedicare shows public-source Medicare data for Shemin Gupta, MD (NPI 1609015528), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shemin Gupta, MD have ACO affiliation data?

Shemin Gupta, MD is shown with ACO affiliation data for Complete Health Accountable Care LLC (REACH, ACO ID D0036).

What billing organization is linked to Shemin Gupta, MD?

Shemin Gupta, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Shemin Gupta, MD have Open Payments data?

Shemin Gupta, MD has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.